Locally Advanced Non-Small Cell Lung Cancer: Clinical Trials

3 recruiting. 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	3	Recruiting 3

Follow Locally Advanced Non-Small Cell Lung Cancer: new trials by email Literature Review of Locally Advanced Non-Small Cell Lung Cancer trials Research Report on Locally Advanced Non-Small Cell Lung Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC PD-L1/VEGF Bispecific Antibody, PD-1 Monoclonal Antibody, Nab-paclitaxel - Locally Advanced Non-Small Cell Lung Cancer	Phase 3	Recruiting	Shanghai Pulmonary Hospital, Shanghai, China	290	2026-05-01	2026-10-07
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC Hypofractionated Radiation Therapy, Conventionally Fractionated Radiation Therapy, Concurrent Chemotherapy - Locally Advanced Non-Small Cell Lung Cancer	Phase 3	Recruiting	Sun Yat-sen University	311	2025-07-01	2025-07-23
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer Neoadjuvant therapy, Hypo-RT and concurrent chemotherapy, CFRT and concurrent chemotherapy - Neoadjuvant Therapy, Concurrent Chemoradiotherapy	Phase 3	Recruiting	Sun Yat-sen University	497	2024-11-30	2025-07-24

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Carboplatin (1)  ·  Neoadjuvant Therapy (1)  ·  Surgical Procedures, Operative (1)  ·  spartalizumab (1)

Sponsors

Sun Yat-sen University (2)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (3)

Top investigators

Hui Liu, Professor (2)  ·  Peng Zhang, PhD (1)